Cargando…

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs

Glycogen storage disease type Ia (GSDIa) is caused by defective glucose-6-phosphatase, a key enzyme in carbohydrate metabolism. Affected individuals cannot release glucose during fasting and accumulate excess glycogen and fat in the liver and kidney, putting them at risk of severe hypoglycaemia and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derks, Terry G. J., Rodriguez-Buritica, David F., Ahmad, Ayesha, de Boer, Foekje, Couce, María L., Grünert, Sarah C., Labrune, Philippe, López Maldonado, Nerea, Fischinger Moura de Souza, Carolina, Riba-Wolman, Rebecca, Rossi, Alessandro, Saavedra, Heather, Gupta, Rupal Naik, Valayannopoulos, Vassili, Mitchell, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621617/ https://www.ncbi.nlm.nih.gov/pubmed/34836082 http://dx.doi.org/10.3390/nu13113828

Ejemplares similares

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia
por: Perry, Ariane, et al.
Publicado: (2020)

The rs2229611 (G6PC:c.*23 T>C) is associated with glycogen storage disease type Ia in Brazilian patients
por: Pinheiro, Franciele Cabral, et al.
Publicado: (2020)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia
por: Monteiro, Vaneisse C. L., et al.
Publicado: (2021)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases
por: Heiner-Fokkema, M. Rebecca, et al.
Publicado: (2020)

The potential of dietary treatment in patients with glycogen storage disease type IV
por: Derks, Terry G. J., et al.
Publicado: (2020)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
por: Haring, Martijn P.D., et al.
Publicado: (2022)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Hepatic glycogen storage diseases are associated to microbial dysbiosis
por: Colonetti, Karina, et al.
Publicado: (2019)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring
por: Hoogeveen, Irene J., et al.
Publicado: (2018)

Correction: Hepatic glycogen storage diseases are associated to microbial dysbiosis
por: Colonetti, Karina, et al.
Publicado: (2019)

Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023)

A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
por: Peeks, Fabian, et al.
Publicado: (2021)

Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report
por: Cohn, Aviva, et al.
Publicado: (2017)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

A Novel Mutation in a Newborn Baby Leading to Glycogen Storage Disease Type Ia
por: Dorum, S, et al.
Publicado: (2018)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

A retrospective study of eating and psychosocial problems in patients with hepatic glycogen storage diseases and idiopathic ketotic hypoglycemia: Towards a standard set of patient‐reported outcome measures
por: Venema, Annieke, et al.
Publicado: (2021)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia
por: Cho, Jun-Ho, et al.
Publicado: (2017)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone
por: Wu, Shimin, et al.
Publicado: (2022)

Double filtration plasmapheresis for pregnancy with hyperlipidemia in glycogen storage disease type Ia: A case report
por: Wang, Jie, et al.
Publicado: (2022)

Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis
por: Sato, Hirotaka, et al.
Publicado: (2022)

A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report
por: Yin, Maohui, et al.
Publicado: (2022)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI
por: Grünert, Sarah Catharina, et al.
Publicado: (2021)

A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature
por: Ai, Jiaoyu, et al.
Publicado: (2020)

Glycogen storage disease type Ia misdiagnosed as multiple acyl-coenzyme A dehydrogenase deficiency by mass spectrometry
por: Du, Juan, et al.
Publicado: (2022)

From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
por: Chandler, Randy J.
Publicado: (2023)

Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome
por: Sentner, Christiaan P., et al.
Publicado: (2016)

Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations
por: Rossi, Alessandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_03mi12tklcauqalot4iu800vjk